Aging is associated with weakened structural connectivity between the ventromedial prefrontal cortex (vPFC) and the amygdala, yet older adults often exhibit lower trait anxiety [1]. This paradox suggests that compensatory mechanisms may counteract diminished top‑down regulation. We hypothesize that age‑dependent increases in gut‑microbiota‑derived indole metabolites enhance SK channel activity specifically in corticotropin‑releasing factor (CRF)‑expressing neurons of the bed nucleus of the stria terminalis (BNST), thereby reducing their intrinsic excitability and offsetting the impact of vPFC‑amygdala decoupling on anxiety‑related behavior.

Mechanistically, indoles have been shown to restore SK channel currents and attenuate basolateral amygdala (BLA) hyperexcitability in germ‑free mice [8]. CRF neurons in the BNST regulate fear extinction bidirectionally: their activation accelerates extinction via serotonin 5‑HT2C receptors, while their hypersensitivity drives extinction failure [3][4][5]. If indoles selectively potentiate SK‑mediated afterhyperpolarization in these CRF cells, the net effect would be decreased CRF release, reduced downstream amygdala activation, and improved extinction memory despite weaker vPFC‑amygdala structural links.

Testable predictions:

1. Aged mice will exhibit elevated plasma indole concentrations compared with young adults.
2. Whole‑cell patch‑clamp recordings from BNST CRF neurons in aged mice will reveal larger SK‑mediated currents and lower firing rates than in young mice; this difference will be abolished by the SK blocker apamin.
3. Pharmacological elevation of indoles (e.g., via dietary tryptophan supplementation or probiotic administration) in young mice will mimic the aged phenotype: increased SK currents, reduced CRF neuron excitability, and lowered anxiety‑like behavior in the elevated plus maze.
4. Conversely, CRISPR‑mediated knockdown of SK2 channels specifically in CRF‑expressing BNST neurons of aged mice will rescue excitability, heighten anxiety, and impair fear extinction, even when indole levels are high.
5. Administering a CRF receptor antagonist will not further reduce anxiety in aged mice with elevated indoles, indicating a floor effect, whereas it will markedly decrease anxiety in young mice with low indole tone.

These experiments directly link microbiome metabolism, ion channel physiology, and circuit‑level regulation of anxiety. If confirmed, the hypothesis would reframe age‑related anxiety resilience as a neurochemical compensatory process rather than a passive consequence of declining prefrontal control, and it would suggest indole‑based strategies as prophylactic interventions for anxiety disorders across the lifespan.